Skip to main content
. 2023 Oct 3;67:102914. doi: 10.1016/j.redox.2023.102914

Table 2.

Demographic characteristics of study participants: Healthy vs. COVID-19 hospital patients.

Parameter
Controls
COVID-19 patients
p-value
Subjects n = 48
n = 48
mean ± SD mean ± SD
Age (years) 69.4 ± 16.5 69.3 ± 16.7
Sex (females/males) 23/25 23/25
DNA damage parameters
Lysis (%) 1.78 ± 0.54 2.03 ± 0.74 0.070
Netto FPG (% Tail DNA) 7.86 ± 2.34 9.21 ± 5.11 0.106
H2O2 (% Tail DNA) 11.44 ± 2.82 12.44 ± 2.90 0.083
Oxidative stress parameters
FRAP (μmol/L) 982 ± 228 956 ± 256 0.374
GSH (μmol/L) 15.14 ± 2.96 14.35 ± 3.73 0.061
GSSG (μmol/L) 10.26 ± 2.58 8.17 ± 3.80 <0.001
GSH/GSSG ratio 1.57 ± 0.54 1.96 ± 0.79 0.004
MDA (μmol/L) 1.55 ± 0.40 1.56 ± 0.58 0.629
Blood parameters
Erythrocytes (T/L) 4.88 ± 1.15 4.33 ± 0.69 0.005
Leucocytes (G/L) 6.33 ± 1.60 6.71 ± 3.53 0.498
Lymphocytes (G/L) 1.98 ± 0.55 1.29 ± 1.28 <0.001
hs-CRP (mg/L) 2.00 ± 2.34 76.88 ± 72.04 <0.001
HDL (mg/dL) 63.00 ± 15.26 33.19 ± 11.99 <0.001
LDL (mg/dL) 144.50 ± 43.61 81.56 ± 35.14 <0.001
Total cholesterol (mg/dL) 229.40 ± 46.00 136.6 ± 40.22 <0.001
Blood glucose (mg/dL) 104.40 ± 26.20 128.1 ± 68.76 0.029
ALAT (U/L) 27.44 ± 25.09 38.49 ± 35.93 0.093
ASAT (U/L) 26.69 ± 13.83 40.88 ± 27.34 0.030
UCB (μmol/L) 3.80 ± 2.81 2.63 ± 3.11 <0.001
Vitamin D serum level (ng/mL) 22.6 ± 12.5 22.4 ± 9.2 0.755

Data are presented as mean ± standard deviation, p-values are calculated using Mann-Whitney U test for measuring gender differences, significant differences are highlighted with bold numbers. Controls and COVID-19 hospital patients are age and sex-matched. FPG: formamidopyrimidine DNA glycosylase, FRAP: ferric reducing ability potential; GSH:γ-glutamyl-cysteinyl-glycine; GSSG: glutathione disulfide; MDA: malondialdehyde; hs-CRP: high sensitivity c-reactive protein; ALAT: alanine-minotransferase; ASAT: aspartate-aminotransferase, UCB: unconjugated bilirubin; HDL: high density lipoprotein; LDL: low density lipoprotein.